Antiretroviral treatment-based cost saving interventions may offset expenses for new patients and earlier treatment start
Author:
Affiliation:
1. National Institute for Infectious Diseases ‘L. Spallanzani’; Rome Italy
2. Laziosanità-Agency for Public Health, Lazio Region; Rome Italy
3. Local Health Unit Roma A; Rome Italy
Publisher
Wiley
Subject
Pharmacology (medical),Infectious Diseases,Health Policy
Reference51 articles.
1. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies;Antiretroviral Therapy Cohort Collaboration;Lancet,2008
2. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries;Zwahlen;Int J Epidemiol,2009
3. The cost effectiveness of combination antiretroviral therapy for HIV disease;Freedberg;N Engl J Med,2001
4. The survival benefits of AIDS treatment in the United States;Walensky;J Infect Dis,2006
5. The lifetime cost of current human immunodeficiency virus care in the United States;Schackman;Med Care,2006
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patient-reported outcomes among people living with HIV on single- versus multi-tablet regimens: Data from a real-life setting;PLOS ONE;2022-01-13
2. Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries;Expert Review of Pharmacoeconomics & Outcomes Research;2020-01-02
3. De‐simplifying single‐tablet antiretroviral treatments: uptake, risks and cost savings;HIV Medicine;2019-01-11
4. Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?;Journal of the International Association of Providers of AIDS Care (JIAPAC);2019-01-01
5. A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV;AIDS Research and Therapy;2018-10-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3